摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-methyl-N-((3-methylbenzo[b]thiophen-2-yl)methyl)acrylamide | 335034-49-6

中文名称
——
中文别名
——
英文名称
N-methyl-N-((3-methylbenzo[b]thiophen-2-yl)methyl)acrylamide
英文别名
N-methyl-N-(3-methyl-benzo[b]thiophen-2-ylmethyl)acrylamide;N-methyl-N-[(3-methyl-1-benzothiophen-2-yl)methyl]prop-2-enamide
N-methyl-N-((3-methylbenzo[b]thiophen-2-yl)methyl)acrylamide化学式
CAS
335034-49-6
化学式
C14H15NOS
mdl
——
分子量
245.345
InChiKey
CDIXJRGFCMKXCN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    48.6
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FATTY ACID BIOSYSNTHESIS FOR BACTERIAL INFECTIONS
    申请人:VITAS PHARMA RESEARCH PRIVATE LIMITED
    公开号:US20140249170A1
    公开(公告)日:2014-09-04
    The present invention relates to novel heterocyclic compounds which specifically inhibit bacterial FabI and can be used for the treatment of Staphylococcal infections.
    这项发明涉及一种新型杂环化合物,可以特异性地抑制细菌FabI,并可用于治疗葡萄球菌感染。
  • [EN] HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY<br/>[FR] COMPOSES HETEROCYCLIQUES, PROCEDES DE PRODUCTION DE CEUX-CI ET UTILISATION DE CEUX-CI DANS UN TRAITEMENT
    申请人:AFFINIUM PHARM INC
    公开号:WO2004052890A1
    公开(公告)日:2004-06-24
    In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.
    在某种程度上,本发明涉及公式(I)的抗菌化合物,其中A是一个双环杂芳基环或三环环,R2是一个杂环残基;L是一个键,或者L是烷基,烯基或环烷基。
  • [EN] FAB I INHIBITORS<br/>[FR] INHIBITEURS DE FAB I
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2001027103A1
    公开(公告)日:2001-04-19
    Compounds of formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections. In said formula, (A) is (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n), (o) or (p); (I) wherein R1 is H or C¿1-4?alkyl; R?2¿ is H, C¿1-4?alkyl or C3-6cycloalkyl; R?3¿ is (q), (r), (s), (t), (u), (v) or (w); R4 is H or C¿1-4?alkyl; (x) indicates that one of the two designated bonds is a double bond and the other is a single bond; R?5¿ is CH¿2? when the bond to which it is attached is a double bond; or R?5¿ is H or C¿1-4?alkyl when the bond to which it is attached is a single bond; R?6¿ is H or C¿1-4?alkyl; R?7¿ is H, C¿1-6?alkyl or -C0-6alkyl-Ar; Y is H, C1-4alkyl, N(R')2, NHC(O)R', NHCH2C(O)R' or NHC(O)CH=CHR'; each X independently is H, C1-4alkyl, CH2OH, OR', SR', CN, N(R')2, CH2N(R')2, NO2, CF3, CO2R', CON(R')2, COR', NR'C(O)R', F, Cl, Br, I or -S(O)rCF3; W is S or O, Q is H or C1-4alkyl; M is CH2 or O; L is CH2 or C(O); E is O or NR'; each R' independently is H, C1-6alkyl or -C0-6alkyl-Ar; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
    公开了式(I)的化合物,它们是Fab I抑制剂,可用于治疗细菌感染。在所述式中,(A)是(a),(b),(c),(d),(e),(f),(g),(h),(i),(j),(k),(l),(m),(n),(o)或(p);(I),其中R1为H或C1-4烷基; R?2¿为H,C1-4烷基或C3-6环烷基; R?3¿为(q),(r),(s),(t),(u),(v)或(w); R4为H或C1-4烷基;(x)表示两个指定键中的一个是双键,另一个是单键;当其所连接的键是双键时,R?5¿为CH2;当其所连接的键是单键时,R?5¿为H或C1-4烷基; R?6¿为H或C1-4烷基; R?7¿为H,C1-6烷基或-C0-6烷基-Ar; Y为H,C1-4烷基,N(R')2,NHC(O)R',NHCH2C(O)R'或NHC(O)CH = CHR';每个X独立地为H,C1-4烷基,CH2OH,OR',SR',CN,N(R')2,CH2N(R')2,NO2,CF3,CO2R',CON(R')2,COR',NR'C(O)R',F,Cl,Br,I或-S(O)rCF3; W为S或O,Q为H或C1-4烷基; M为CH2或O; L为CH2或C(O); E为O或NR';每个R'独立地为H,C1-6烷基或-C0-6烷基-Ar; r为0、1或2;或其药学上可接受的盐。
  • FAB I inhibitors
    申请人:Miller H. William
    公开号:US20050250810A1
    公开(公告)日:2005-11-10
    Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    公式(I)的化合物被揭示为Fab I抑制剂,可用于治疗细菌感染。
  • Compositions comprising multiple bioactive agents, and methods of using the same
    申请人:Berman M. Judd
    公开号:US20060142265A1
    公开(公告)日:2006-06-29
    In part, the present invention is directed to compositions comprising a FabI inhibitor and at least one other bioactive agent. In another part, the present invention is directed to antibacterial compositions comprising a compound of formulas I-III and at least one other antibacterial agent.
    本发明的一部分涉及含有FabI抑制剂和至少一种其他生物活性剂的组合物。另一部分,本发明涉及含有I-III式化合物和至少一种其他抗菌剂的抗菌组合物。
查看更多

同类化合物